Refractory B acute lymphoblastic leukemia

Clinical trials for Refractory B acute lymphoblastic leukemia explained in plain language.

Never miss a new study

Get alerted when new Refractory B acute lymphoblastic leukemia trials appear

Sign up with your email to follow new studies for Refractory B acute lymphoblastic leukemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 5 Not yet recruiting 1 Not yet finished but already full! 3 Completed 1 Terminated 2

New antibody drug tested in patients with relapsed blood cancers

Disease control Completed

This early-stage trial tested the safety and best dose of flotetuzumab, an antibody drug, in 13 patients with advanced blood cancers that had come back or stopped responding to treatment. The drug works by blocking cancer cell growth. The main goal was to see what side effects oc…

Matched conditions: REFRACTORY B ACUTE LYMPHOBLASTIC LEUKEMIA

Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control

Last updated Jun 27, 2026 09:00 UTC

Refractory B acute lymphoblastic leukemia

Get alerted when new Refractory B acute lymphoblastic leukemia trials appear

New antibody drug tested in patients with relapsed blood cancers